Mid-Tech companies are companies that answer three criteria; (a) The technology is targeted at low-tech, or non-tech industries (b) The R&D needs, in order to develop a market ready product, are relatively small (e.g. less than $5m) (c) Defendable intellectual property.
Mid-tech companies therefore face less market and R&D risks, and so their typical challenges are around commercialization and go-to-market. Example sectors of Mid-tech companies are industrial technologies, water and energy, consumer innovations, medical devices, materials, etc.
The Wanaka Capital team brings commercialization, financial and strategic skills and experiences, and a broad international business network - that are particularly relevant to Mid-Tech companies.
Wanaka Capital Partners is managed by Mr. Ronen Melnik, Mr. Avner Ben Yeshaya and Dr. Avi Shani.
8 years at McKinsey & Company, Co-founder of Tel Aviv office.
Served clients in banking, chemicals, airlines, VC, High-Tech, worked in the UK, Italy and Israel.
Pilot and flight instructor in the Israeli air force.
Private investor in Mid-Tech companies since 2001.
BA in economics and management, Tel Aviv University, MBA from Wharton.
Prior to joining Wanaka, Mr. Ben Yeshaya served as the head of private equity and head of research at Clal Insurance, Israel's largest insurance company.
Previously, he was a Senior Equity Analyst at Gmul Sahar Securities research department.
Ben Yeshaya holds an MBA and a BA of Economics from the Ben-Gurion University of the Negev.
Prior to joining Wanaka, Dr. Shani was the General Manager and founder of Kineticure ltd., an IBV group company, which developed advanced solutions for arthritis. He led the company from inception to an exit stage and was also a team member of the screening & due diligence team of IBV group.
Dr Shani has diversified hands-on experience in different stages and aspects of medical devices and biotechnology projects. Once a family physician, Dr. Shani holds an M.D. and M.B.A degrees, both from the Hebrew University in Jerusalem.
8 years at McKinsey & Company, Co-founder of Tel Aviv office.
Served clients in banking, chemicals, airlines, VC, High-Tech, worked in the UK, Italy and Israel.
Pilot and flight instructor in the Israeli air force.
Private investor in Mid-Tech companies since 2001.
BA in economics and management, Tel Aviv University, MBA from Wharton.
Prior to joining Wanaka, Mr. Ben Yeshaya served as the head of private equity and head of research at Clal Insurance, Israel's largest insurance company.
Previously, he was a Senior Equity Analyst at Gmul Sahar Securities research department.
Ben Yeshaya holds an MBA and a BA of Economics from the Ben-Gurion University of the Negev.
Prior to joining Wanaka, Dr. Shani was the General Manager and founder of Kineticure ltd., an IBV group company, which developed advanced solutions for arthritis. He led the company from inception to an exit stage and was also a team member of the screening & due diligence team of IBV group.
Dr Shani has diversified hands-on experience in different stages and aspects of medical devices and biotechnology projects. Once a family physician, Dr. Shani holds an M.D. and M.B.A degrees, both from the Hebrew University in Jerusalem.